CN102515276B - A method for preparing manganese dioxide nanoparticles based on bovine serum albumin as a template - Google Patents
A method for preparing manganese dioxide nanoparticles based on bovine serum albumin as a template Download PDFInfo
- Publication number
- CN102515276B CN102515276B CN2011104516129A CN201110451612A CN102515276B CN 102515276 B CN102515276 B CN 102515276B CN 2011104516129 A CN2011104516129 A CN 2011104516129A CN 201110451612 A CN201110451612 A CN 201110451612A CN 102515276 B CN102515276 B CN 102515276B
- Authority
- CN
- China
- Prior art keywords
- manganese dioxide
- bovine serum
- serum albumin
- dioxide nanoparticles
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- NUJOXMJBOLGQSY-UHFFFAOYSA-N manganese dioxide Chemical compound O=[Mn]=O NUJOXMJBOLGQSY-UHFFFAOYSA-N 0.000 title claims abstract description 61
- 239000002105 nanoparticle Substances 0.000 title claims abstract description 37
- 238000000034 method Methods 0.000 title claims abstract description 34
- 108091003079 Bovine Serum Albumin Proteins 0.000 title claims abstract description 26
- 229940098773 bovine serum albumin Drugs 0.000 title claims abstract description 25
- 238000002360 preparation method Methods 0.000 claims abstract description 21
- 230000008569 process Effects 0.000 claims abstract description 15
- 238000006243 chemical reaction Methods 0.000 claims abstract description 12
- 238000000502 dialysis Methods 0.000 claims abstract description 11
- 230000015572 biosynthetic process Effects 0.000 claims abstract description 7
- 238000003786 synthesis reaction Methods 0.000 claims abstract description 4
- 238000003756 stirring Methods 0.000 claims description 15
- 239000011572 manganese Substances 0.000 claims description 6
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 4
- 239000001301 oxygen Substances 0.000 claims description 4
- 229910052760 oxygen Inorganic materials 0.000 claims description 4
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 claims description 3
- 229910052748 manganese Inorganic materials 0.000 claims description 3
- 230000005291 magnetic effect Effects 0.000 claims description 2
- 238000013019 agitation Methods 0.000 claims 1
- 239000012154 double-distilled water Substances 0.000 claims 1
- 229910001437 manganese ion Inorganic materials 0.000 claims 1
- 239000008363 phosphate buffer Substances 0.000 claims 1
- 238000009423 ventilation Methods 0.000 claims 1
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 abstract description 24
- 239000000243 solution Substances 0.000 abstract description 23
- 239000002086 nanomaterial Substances 0.000 abstract description 19
- UOGMEBQRZBEZQT-UHFFFAOYSA-L manganese(2+);diacetate Chemical compound [Mn+2].CC([O-])=O.CC([O-])=O UOGMEBQRZBEZQT-UHFFFAOYSA-L 0.000 abstract description 8
- 239000008055 phosphate buffer solution Substances 0.000 abstract description 8
- 229940071125 manganese acetate Drugs 0.000 abstract description 7
- 239000003153 chemical reaction reagent Substances 0.000 abstract description 4
- 230000008901 benefit Effects 0.000 abstract description 2
- 238000006555 catalytic reaction Methods 0.000 abstract description 2
- 238000010521 absorption reaction Methods 0.000 abstract 1
- 239000011259 mixed solution Substances 0.000 abstract 1
- 238000000926 separation method Methods 0.000 abstract 1
- 239000002245 particle Substances 0.000 description 19
- 102000004169 proteins and genes Human genes 0.000 description 12
- 108090000623 proteins and genes Proteins 0.000 description 12
- 239000013078 crystal Substances 0.000 description 8
- 238000000703 high-speed centrifugation Methods 0.000 description 7
- 238000003760 magnetic stirring Methods 0.000 description 7
- 230000003019 stabilising effect Effects 0.000 description 7
- 230000000694 effects Effects 0.000 description 6
- 102000009027 Albumins Human genes 0.000 description 5
- 108010088751 Albumins Proteins 0.000 description 5
- 239000012888 bovine serum Substances 0.000 description 5
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 230000001276 controlling effect Effects 0.000 description 3
- 238000002329 infrared spectrum Methods 0.000 description 3
- 150000002500 ions Chemical class 0.000 description 3
- 230000006911 nucleation Effects 0.000 description 3
- 238000010899 nucleation Methods 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- QPLDLSVMHZLSFG-UHFFFAOYSA-N Copper oxide Chemical compound [Cu]=O QPLDLSVMHZLSFG-UHFFFAOYSA-N 0.000 description 2
- 238000002441 X-ray diffraction Methods 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 238000002983 circular dichroism Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 238000003384 imaging method Methods 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- YEXPOXQUZXUXJW-UHFFFAOYSA-N oxolead Chemical compound [Pb]=O YEXPOXQUZXUXJW-UHFFFAOYSA-N 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000001338 self-assembly Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000002194 synthesizing effect Effects 0.000 description 2
- 238000010189 synthetic method Methods 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- UCKMPCXJQFINFW-UHFFFAOYSA-N Sulphide Chemical compound [S-2] UCKMPCXJQFINFW-UHFFFAOYSA-N 0.000 description 1
- 239000005864 Sulphur Substances 0.000 description 1
- 210000002659 acromion Anatomy 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 238000005054 agglomeration Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 239000000090 biomarker Substances 0.000 description 1
- CXKCTMHTOKXKQT-UHFFFAOYSA-N cadmium oxide Inorganic materials [Cd]=O CXKCTMHTOKXKQT-UHFFFAOYSA-N 0.000 description 1
- CFEAAQFZALKQPA-UHFFFAOYSA-N cadmium(2+);oxygen(2-) Chemical compound [O-2].[Cd+2] CFEAAQFZALKQPA-UHFFFAOYSA-N 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000001142 circular dichroism spectrum Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 229960004643 cupric oxide Drugs 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 238000002296 dynamic light scattering Methods 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 238000004070 electrodeposition Methods 0.000 description 1
- 238000002265 electronic spectrum Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000002173 high-resolution transmission electron microscopy Methods 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 238000001027 hydrothermal synthesis Methods 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 239000011147 inorganic material Substances 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N iron oxide Inorganic materials [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 1
- UBXWAYGQRZFPGU-UHFFFAOYSA-N manganese(2+) oxygen(2-) titanium(4+) Chemical compound [O--].[O--].[Ti+4].[Mn++] UBXWAYGQRZFPGU-UHFFFAOYSA-N 0.000 description 1
- MIVBAHRSNUNMPP-UHFFFAOYSA-N manganese(2+);dinitrate Chemical compound [Mn+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O MIVBAHRSNUNMPP-UHFFFAOYSA-N 0.000 description 1
- CNFDGXZLMLFIJV-UHFFFAOYSA-L manganese(II) chloride tetrahydrate Chemical compound O.O.O.O.[Cl-].[Cl-].[Mn+2] CNFDGXZLMLFIJV-UHFFFAOYSA-L 0.000 description 1
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 1
- 239000002082 metal nanoparticle Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000002127 nanobelt Substances 0.000 description 1
- 239000002159 nanocrystal Substances 0.000 description 1
- 239000002071 nanotube Substances 0.000 description 1
- 239000002070 nanowire Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 229910000510 noble metal Inorganic materials 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- NDLPOXTZKUMGOV-UHFFFAOYSA-N oxo(oxoferriooxy)iron hydrate Chemical compound O.O=[Fe]O[Fe]=O NDLPOXTZKUMGOV-UHFFFAOYSA-N 0.000 description 1
- 239000003973 paint Substances 0.000 description 1
- 238000002186 photoelectron spectrum Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 238000004098 selected area electron diffraction Methods 0.000 description 1
- 230000005476 size effect Effects 0.000 description 1
- 239000002594 sorbent Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 229920002994 synthetic fiber Polymers 0.000 description 1
- 238000005979 thermal decomposition reaction Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 238000004383 yellowing Methods 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
Images
Landscapes
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
- Peptides Or Proteins (AREA)
Abstract
The invention provides a preparation method for controlling to synthesize manganese dioxide nanoparticles with bovine serum albumin as a biological template, which belongs to the technical field of manganese dioxide synthesis and nano materials. A process has the following steps that: a certain amount of bovine serum albumin is dissolved in phosphate buffer solution, manganese acetate solution is added in, the mixed solution is mixed and reacts for 2min, then sodium hydroxide is added in, the pH value is adjusted to be strong alkaline, the reaction is carried out for 6h to 8h at room temperature, and the manganese dioxide nanoparticles with the grain size of 4.8nm are obtained after 2 days of dialysis and high-speed centrifugal separation. The method has the advantages that: the preparation method is simple, the reaction conditions are mild, the cost is low, little reagent is required, the use is environmental-friendly, and the manganese dioxide nanoparticles with good dispersibility, good stability, good biocompatibility, smaller grain size, consistent dimension and uniform shape and appearance are obtained. We think the manganese dioxide nanoparticles with smaller and uniform grain size have huge potential application prospect in absorption, catalysis, bio-marking and other fields.
Description
Technical field
The present invention relates to a kind of preparation method of manganese dioxide nano particle, belong to the synthetic and technical field of nano material of Manganse Dioxide, specifically a kind of is the method for the synthetic manganese dioxide nano particle of biological template contral based on bovine serum albumin.
Background technology
Growing along with nanosecond science and technology, the quantum size effect that nano particle has, small-size effect, surface effects and macroscopical channel effect etc. arouse widespread concern.These special character make nano material gather around and have broad application prospects at aspects such as optics, electricity, magnetics, catalysis.In recent years, Manganse Dioxide has caused the extensive concern in each field as a kind of oxide compound with essential industry purposes.Therefore, nano-manganese dioxide with its unique structure, excellent performance and cheap cost at secondary cell, stealthy, magneticsubstance, catalyzer, sorbent material, ion-exchange, wet sensitive and gas sensor, communication, high frequency circuit, (V. Bharat even all is widely used at the aspects such as colorant of paint or coating, R. Boppana and F. Jiao
Chem. Commun., 2011,47,8973-8975; F. Y. Cheng, J. Chen, X. L. Gou and P. W. Shen,
Adv. Mater., 2005,17,2753-2756.).
Find after deliberation, the granular size of nanometer titanium dioxide manganese material, pattern and crystal formation are very large to its performance impact.Therefore, preparation method's tool of research nano material of manganese dioxide has very important significance.At present, existing bibliographical information synthesized various nanometer rod, nano wire, nano belt, nanotube and 3-D nano, structure manganese bioxide material (X. Wang and Y. Li,
Chem. Commun., 2002,7,764-765; R. Ma, Y. Bando, L. Zhang and T. Sasaki,
Adv. Mater., 2004,16,918-922; Z. Liu, R. Ma, Y. Ebina, K. Takada and T. Sasaki,
Chem. Mater., 2007,19,6504-6512; D. Zheng, S. Sun, W. Fan, H. Yu, C. Fan, G. Cao, Z. Yin and X. Song,
J. Phys. Chem. B, 2005,109,16439-16443.).On the whole, the method for synthetic nano material of manganese dioxide mainly comprises: via sol-gel template method (B. B. Lakshmi, C. J. Patrissi and C. R. Martin,
Chem. Mater., 1997,9,2544-2550.), thermal decomposition method (D. Zitoun, N. Pinna, N. Frolet and C. Belin,
J. Am. Chem. Soc., 2005,127,15034-15035.), circumfluence method (J. C. Villegas, L. J. Garces, S. Gomez, J. P. Duand and S. L. Suib,
Chem. Mater., 2005,17,1910-1918.), solid phase method (Y. S. Ding, X. F. Shen, S. Sithambaram, S. Gomez, R. Kumar, V. M. Crisostomo and S. L. Suib,
Chem. Mater., 2005,17,5382-5389.), electrochemical deposition method (M. S. Wu, J. T. Lee, Y. Y. Wang and C. C. Wan,
J. Phys. Chem. B, 2004,108,16331-16333.) and hydrothermal method (X. Wang and Y. Li,
Chem. Eur. J., 2003,9,300-306.) etc.Make a general survey of the whole bag of tricks of synthetic nano material of manganese dioxide, great majority need the condition of High Temperature High Pressure usually, complicated operation, and generally need the reagent used more, caused waste.Wayward due to speed of response, products therefrom often exceeds nanometer range, and the reunion that particle easily occurs causes dispersed bad.And in the application of nano material, catalytic field especially, the small size of homogeneous and polymolecularity are vital.Regrettably, at present, be less than the particle diameter of 5 nm and the preparation method of dispersed extraordinary manganese dioxide nano particle has no report for synthetic.Therefore, the nano material of manganese dioxide that how utilizes at normal temperatures and pressures easy operation to obtain small particle size be one highly significant and be rich in challenging research work.
In recent years, the standby nano material of biological template legal system has caused attention widely.Biological tissue and biomacromolecule that the biological template nano materials refers to have ad hoc structure are template, utilize biological self-assembly and space confinement effect thereof, by methods such as physics, chemistry according to design requirements to size, pattern, the structure of synthetic materials, arrange etc. and to control, thereby form new nano material or nanostructure (Ou Yangjianming
Chemical progress, 2005,17 (4), 749-756.).Wherein, protein molecule is owing to having complicated space structure and multiple different biological function, for the pattern of nano material play vital effect (Xue Zhonghui, Dang Yazheng, CHEN XINHUA, Guan Rongfeng,
Xuchang College's journal, 2008,27 (5), 107-111.).Therefore, Study on Protein regulation and control nanoparticle synthetic enjoys favor.Be subjected to the process of protein regulation synthesis oxide nanoparticle generally can be divided into ionic bonding, oxidation, nucleation, growth four-stage (M. B. Dickerson, K. H. Sandhage and R. R. Naik,
Chem. Rev., 2008,108,4935-4978.).In regulation and control nanoparticle nucleation process, amino-acid residue in prlmary structure of protein plays an important role to the identification of mineral ion, secondary protein structure can adapt to by the variation of conformation the molecular structure of mineral crystal, thereby reach purpose (the L. B. Gower of the oriented growth of the regulation and control nucleation of crystal and crystal face
Chem. Rev., 2008,108,4551-4627.).The protein of take is as the advantage of the method for biological template synthesizing nano-particle: the reaction conditions gentleness, do not need heating and pressurizing, and generally can react at normal temperatures; Specific, the good biocompatibility of appearance of nano material rule, uniform particle diameter, crystal formation of preparation, have the prospect of biological fields such as being applied to immune labeled, bio-imaging, pharmaceutical carrier.
At present, the biological template method was widely used in simple, green characteristic in synthesizing of the multiple inorganic materials such as noble metal nano particles, oxide compound, sulfide, mixture.But up to now, utilize the method for the synthetic manganese dioxide nano particle of biological template method to have no report.
Summary of the invention
The objective of the invention is to solve the defects such as experiment condition harshness in the synthetic Manganse Dioxide method of tradition, complicated operation, dispersed bad, easy reunion, particle diameter are larger, it is the simple method for preparing of the Manganse Dioxide of 4.8 nm for biological template contral synthesizes particle diameter that a kind of bovine serum albumin that utilizes is provided.The present invention utilizes self-assembly characteristics, the space confinement effect of biological template and improves and strict molecular recognition function, by physics, chemical action, the synthetic of nano material carried out to accuracy controlling, thereby obtain having the nano material of manganese dioxide of specific morphology and structure.
For achieving the above object, the present invention is by the following technical solutions:
The preparation method of bovine serum albumin regulation and control manganese dioxide nano particle: in the process of preparation, add the phosphate buffer solution of bovine serum albumin in 50 mL single port bottles.Then add the aqueous solution that manganese acetate the is made into source as mn ion, on magnetic stirring apparatus, at the uniform velocity stir 2 min, temperature of reaction is 20 ℃ of normal temperature.Then adding aqueous sodium hydroxide solution to regulate pH is strong basicity, from colourless yellowing, continues to stir 6-8 hour after the solution several minutes, and solution becomes stabilising system.Through dialysis 48 hours, then high speed centrifugation separated, and can obtain the nanoparticle Manganse Dioxide of uniform particle diameter.Be kept in 4 ℃ of conditions and store.
The present invention has following beneficial effect:
A) the prepared nano material Manganse Dioxide of the present invention has the particle diameter of less homogeneous, good dispersiveness and stability, and the not sedimentation of standing some months, do not produce agglomeration.
B) template of the present invention is the protein bovine serum albumin, nontoxic, a kind of biological template reagent of green, and, by the synthetic manganese dioxide nano particle good biocompatibility of this biological template method, can be applicable in the biological fields such as biomarker, immunoassay, bio-imaging analysis.
C) preparation method's mild condition of the present invention, cost low, simple to operate, can react at normal temperatures and pressures, not need to add in addition organic stabilizer/dispersion agent, be conducive to the widespread use of nanoparticle in biological field.With the method for the synthetic Manganse Dioxide of tradition, comparing, overcome that traditional building-up reactions is complicated, the time is long, need that reagent is many, power consumption, the first-class shortcoming of particle diameter inequality, is a kind of synthetic method of simple green.
D) because the present invention has versatility, not only utilize protein molecule can control synthetic other oxide compounds such as zinc oxide, ferric oxide, Cadmium oxide, plumbous oxide, cupric oxide etc. for template, and utilize different protein moleculars can synthesize the inorganic nano material of different-shape, particle diameter, crystal formation, character for template, be a kind of synthetic method of very effective control nanoparticle.
The accompanying drawing explanation
Fig. 1 a, Fig. 1 b and Fig. 1 c show respectively transmission electron microscope (TEM) photo, high-resolution-ration transmission electric-lens (HRTEM) photo and the selected area electron diffraction figure (SAED) of products therefrom.From a figure, finding out, the manganese dioxide nanocrystal that the bovine serum albumin of take makes as template is as spherical, and median size is 4.8 nm and dispersed fine.From data analysis b figure, show that spacing is 0.214 nm, with γ-MnO
2In hexagonal, the spacing of (3 0 1) crystal face matches.Spacing and the γ-MnO of two diffraction rings in c figure
2The spacing of (3 0 1) and (the 31 0) crystal face in the X-ray diffraction of hexagonal (XRD) standard card matches, and proves that products therefrom is γ-MnO
2.
Fig. 2 is the dynamic light scattering figure of product.As can be seen from the figure the median size of Manganse Dioxide is 4.8 nm, and the hydration particle diameter is 7.3 nm.Particle diameter distribution width is narrow, and the Manganse Dioxide uniform particle diameter that the method is synthetic is described.
Fig. 3 is electronic spectrum (a) and the photoelectron spectrum figure (b, c, d) of product.From a and b figure, finding out, the main component of product is carbon, nitrogen, oxygen, sulphur, manganese.From c figure, finding out, in conjunction with can 642.4 eV and 653.9 eV be respectively in Manganse Dioxide Mn 2p3/2 and Mn 2p1/2 in conjunction with can value.D figure is the differential matched curve of sample O1s.As can be seen from the figure, in this sample, there are three kinds of combinations in oxygen, is respectively Mn-O-Mn key, Mn-O-H key and H-O-H key, and further the indirect proof product is Manganse Dioxide.
Fig. 4 is the circular dichroism spectrogram of product.The a figure line means is the circular dichroism spectrogram of pure bovine serum albumin, occurs respectively that at 208 and 222 nm two negative feature acromion bands of a spectrum are characteristic peaks of protein α-helixstructure.What b figure meaned is the circular dichroism spectrum peak that bovine serum albumin is controlled synthetic Manganse Dioxide, the peak of finding 208 nm has moved to 204 nm places, illustrates that protein is in the process of the synthetic Manganse Dioxide of regulation and control, and variation has occurred secondary structure, α-helixstructure reduces gradually, and the beta sheet structure increases.Major cause is the sterically hindered α-helixstructure that is less than of the secondary structure of beta sheet, more is conducive to nanoparticle and enters in protein steric structure and react.So obtaining an important conclusion is that variation has occurred the secondary structure of bovine serum albumin in the process of controlling synthetic Manganse Dioxide.
Fig. 5 is the infrared spectrum of product.As can be seen from the figure, b figure is the infrared spectrum of pure bovine serum albumin, 3311,3071,1654,1540 cm
-1Be respectively-OH ,-the molecule stretching vibration peak of NH-, acid amides I, acid amides II.A figure is the infrared spectrum that bovine serum albumin is controlled synthetic manganese dioxide nano particle.With the contrast of pure bovine serum albumin, can find out-OH and-movement occurred in the stretching vibration peak of NH-.Explanation in controlling synthetic process, mn ion and-OH and-interaction occurred in NH-, thereby take protein has formed nano material of manganese dioxide as template.
Embodiment
Below by embodiment, the preparation method who is the synthetic manganese dioxide nano particle of biological template contral based on bovine serum albumin of the present invention is described further.The present embodiment is implemented take the present invention program under prerequisite, provided detailed embodiment and concrete operating process.
Embodiment 1:
In the process of preparation, 10 mL that add respectively 25 mg bovine serum albumins to be made into, 0.01 mol L
-1Phosphate buffer solution in 4 50 mL single port bottles, then add respectively 5 μ mol manganese acetates, Manganous chloride tetrahydrate, manganous sulfate or manganese nitrate solution, on magnetic stirring apparatus, at the uniform velocity stir 2 min, temperature of reaction is 20 ℃ of normal temperature.Then add 50 μ L, 1 mol L
-1Aqueous sodium hydroxide solution, continue to stir 6-8 hour, and solution becomes stabilising system.Through dialysis, with high speed centrifugation, separated in 48 hours, can obtain the nanoparticle Manganse Dioxide of uniform particle diameter.Be kept in 4 ℃ of conditions and store.
Embodiment 2:
In the process of preparation, 10 mL that add respectively 25 mg bovine serum albumins to be made into, 0.01 mol L
-1Phosphate buffer solution in 3 50 mL single port bottles, then add respectively 5 μ mol manganese acetate solution, on magnetic stirring apparatus, at the uniform velocity stir 2 min, temperature of reaction is 20 ℃ of normal temperature.Then add respectively 50 μ L, 1 mol L
-1Aqueous sodium hydroxide solution, potassium hydroxide aqueous solution or ammoniacal liquor, continue to stir 6-8 hour, and solution becomes stabilising system.Through dialysis, with high speed centrifugation, separated in 48 hours, can obtain the nanoparticle Manganse Dioxide of uniform particle diameter.Be kept in 4 ℃ of conditions and store.
Embodiment 3:
In the process of preparation, 10 mL that add respectively 25 mg bovine serum albumins to be made into, 0.01 mol L
-1Phosphate buffer solution in 11 50 mL single port bottles, then add 5 μ mol manganese acetate solution, on magnetic stirring apparatus, at the uniform velocity stir 2 min, temperature of reaction is 20 ℃ of normal temperature.Then the 1 mol L that adds respectively different amounts
-1Aqueous sodium hydroxide solution is regulated pH and is respectively 8.10,8.35,9.06,10.00,10.68,10.90,11.28,11.38,11.47,11.54,11.62, continues to stir 6-8 hour, and solution becomes stabilising system.Through dialysis, with high speed centrifugation, separated in 48 hours, can obtain the nanoparticle Manganse Dioxide of uniform particle diameter.Be kept in 4 ℃ of conditions and store.
Embodiment 4:
In the process of preparation, 10 mL that add respectively 25 mg bovine serum albumins to be made into, 0.01 mol L
-1Phosphate buffer solution in 10 50 mL single port bottles, then add respectively 5 μ mol manganese acetate solution, on magnetic stirring apparatus, at the uniform velocity stir 2 min, temperature of reaction is respectively 10,20,30,40,50,60,70,80,90,100 ℃.Then add 1 mol L
-1Aqueous sodium hydroxide solution 50 μ L.Continue to stir 6-8 hour, solution becomes stabilising system.Through dialysis, with high speed centrifugation, separated in 48 hours, can obtain the nanoparticle Manganse Dioxide of uniform particle diameter.Be kept in 4 ℃ of conditions and store.
Embodiment 5:
In the process of preparation, the concentration that adds 25 mg bovine serum albumins to be made into 10 mL is respectively 0.00001,0.0001,0.001,0.01,0.1., 1 mol L
-1Phosphate buffer solution in 6 50 mL single port bottles, then add respectively 5 μ mol manganese acetate solution, on magnetic stirring apparatus, at the uniform velocity stir 2 min, temperature of reaction is 20 ℃ of normal temperature.Then add 1 mol L
-1Aqueous sodium hydroxide solution 50 μ L, continue to stir 6-8 hour, and solution becomes stabilising system.Through dialysis, with high speed centrifugation, separated in 48 hours, can obtain the nanoparticle Manganse Dioxide of uniform particle diameter.Be kept in 4 ℃ of conditions and store.
Embodiment 6:
In the process of preparation, add the bovine serum albumin of different amounts to be respectively the 0.01 mol L that 5,25,50,100,125,150 mg are made into 10 mL
-1Phosphate buffer solution in 6 50 mL single port bottles, then add respectively 25 μ mol manganese acetate solution, on magnetic stirring apparatus, at the uniform velocity stir 2 min, temperature of reaction is 20 ℃ of normal temperature.Then add 1 mol L
-1Aqueous sodium hydroxide solution 250 μ L, continue to stir 6-8 hour, and solution becomes stabilising system.Through dialysis, with high speed centrifugation, separated in 48 hours, can obtain the nanoparticle Manganse Dioxide of uniform particle diameter.Be kept in 4 ℃ of conditions and store.
Claims (4)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011104516129A CN102515276B (en) | 2011-12-30 | 2011-12-30 | A method for preparing manganese dioxide nanoparticles based on bovine serum albumin as a template |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011104516129A CN102515276B (en) | 2011-12-30 | 2011-12-30 | A method for preparing manganese dioxide nanoparticles based on bovine serum albumin as a template |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102515276A CN102515276A (en) | 2012-06-27 |
| CN102515276B true CN102515276B (en) | 2013-11-27 |
Family
ID=46286427
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2011104516129A Expired - Fee Related CN102515276B (en) | 2011-12-30 | 2011-12-30 | A method for preparing manganese dioxide nanoparticles based on bovine serum albumin as a template |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102515276B (en) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103041407B (en) * | 2012-12-19 | 2015-02-18 | 深圳先进技术研究院 | Core-shell type nano-contrast agent, preparation method and application thereof |
| CN103041408A (en) * | 2012-12-19 | 2013-04-17 | 深圳先进技术研究院 | Core-shell type nano-contrast agent, preparation method and application thereof |
| CN103042230A (en) * | 2013-01-05 | 2013-04-17 | 西安交通大学 | Preparation method for micron spherical silver powder for electronic paste |
| CN103969445B (en) * | 2014-05-08 | 2015-09-30 | 中南大学 | The preparation of heme-manganese dioxide composites and the method for detecting human IgG thereof |
| CN104401955B (en) * | 2014-10-24 | 2016-11-30 | 西北工业大学 | A kind of preparation method of BSA/Zn3(PO4)3 hybrid nano flower |
| CN106745281A (en) * | 2016-04-28 | 2017-05-31 | 青岛大学 | It is a kind of with the method for filobactivirus templated synthesis manganese dioxide nanowire and application |
| CN106732794A (en) * | 2016-04-28 | 2017-05-31 | 青岛大学 | A kind of preparation method and applications of purple membrane-metal oxide nano composite material |
| CN106075475A (en) * | 2016-07-13 | 2016-11-09 | 上海师范大学 | Bovine serum albumin-coated iron ferric oxide nanoparticles T1-MRI contrast agent and preparation method thereof |
| CN106270546B (en) * | 2016-08-12 | 2018-02-09 | 中国人民解放军第三军医大学军事预防医学院 | A kind of method of protein mediated synthetic modification cerium nano material |
| CN106424753B (en) * | 2016-10-14 | 2018-12-07 | 泉州师范学院 | A kind of MnO2The preparation and its application of-Ag nanocomposite |
| CN108529681A (en) * | 2017-03-06 | 2018-09-14 | 中国科学院深圳先进技术研究院 | Hollow manganese dioxide nano particle and its preparation method and application |
| CN107343957B (en) * | 2017-07-18 | 2020-04-21 | 中南大学 | A kind of black phosphorus/manganese dioxide composite nanomaterial and its preparation method and application |
| CN107812957B (en) * | 2017-10-26 | 2020-03-13 | 太原工业学院 | Method for preparing fluorescent silver nanoparticles based on silver mirror reaction |
| CN109319842A (en) * | 2018-09-29 | 2019-02-12 | 山西大学 | A kind of rapid preparation method of bovine serum albumin-loaded manganese dioxide nanoparticles |
| CN111821316A (en) | 2019-04-19 | 2020-10-27 | 北京大学 | Manganese composition for immune enhancement |
| CN112691120B (en) * | 2019-10-23 | 2022-03-29 | 北京大学 | Application of bivalent manganese in preparation of immune enhancement medicine or anti-tumor medicine |
| CN113546057A (en) * | 2021-06-07 | 2021-10-26 | 昆明理工大学 | A kind of indocyanine green composite nanoparticle and its preparation method and application |
| CN115452816A (en) * | 2022-09-19 | 2022-12-09 | 中华人民共和国兰州海关 | Method for detecting nitrite by ratio absorbance colorimetric method |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080014621A1 (en) * | 2006-07-13 | 2008-01-17 | National Institute Of Aerospace Associates | Fabrication of metal nanoshells |
-
2011
- 2011-12-30 CN CN2011104516129A patent/CN102515276B/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080014621A1 (en) * | 2006-07-13 | 2008-01-17 | National Institute Of Aerospace Associates | Fabrication of metal nanoshells |
Non-Patent Citations (4)
| Title |
|---|
| M. Kanthimathi et al..Nanosized nickel oxide using bovine serum albumin as template.《Materials Letters》.2004,第58卷第2915页实验部分第1段. |
| Nanosized nickel oxide using bovine serum albumin as template;M. Kanthimathi et al.;《Materials Letters》;20040623;第58卷;第2915页实验部分 * |
| 以生物蛋白为模板控制合成MnO2 纳米颗粒;张学萍等;《化学与黏合》;20100430;第32卷(第2期);第2页第1栏第2段、第4段 * |
| 张学萍等.以生物蛋白为模板控制合成MnO2 纳米颗粒.《化学与黏合》.2010,第32卷(第2期),第2页第1栏第2段、第4段. |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102515276A (en) | 2012-06-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102515276B (en) | A method for preparing manganese dioxide nanoparticles based on bovine serum albumin as a template | |
| Liu et al. | One-pot synthesis of ternary CuInS 2 quantum dots with near-infrared fluorescence in aqueous solution | |
| CN102259907B (en) | Porous zinc oxide nano material and preparation method thereof | |
| CN102515252B (en) | Film-coating production technology for nano zinc oxide | |
| CN102633307A (en) | Method for hydrothermally preparing mono-dispersed hollow magnetic nanometer particles | |
| CN101780981B (en) | Hydro-thermal synthesis method of molybdenum dioxide nano particle | |
| Tunusoğlu et al. | Surfactant-assisted formation of organophilic CeO2 nanoparticles | |
| Salavati-Niasari et al. | Sonochemical synthesis of Dy2 (CO3) 3 nanoparticles, Dy (OH) 3 nanotubes and their conversion to Dy2O3 nanoparticles | |
| CN102554217A (en) | Water-soluble nano-copper and preparation method thereof | |
| Davar et al. | Temperature controlled synthesis of SrCO3 nanorods via a facile solid-state decomposition rout starting from a novel inorganic precursor | |
| WO2007026746A1 (en) | Semiconductor nanoparticle and method for manufacturing same | |
| Sulimai et al. | Facile synthesis of CaCO3 and investigation on structural and optical properties of high purity crystalline calcite | |
| Beshkar et al. | Novel dendrite-like CuCr2O4 photocatalyst prepared by a simple route in order to remove of Azo Dye in textile and dyeing wastewater | |
| CN101532169A (en) | Method for hydrothermally synthesizing Alpha-iron oxide red nanocrystalline | |
| CN113428888A (en) | High-dispersion cerium oxide nano sol and preparation method and application thereof | |
| CN103950985B (en) | Nanometer bismuth tungstate of a kind of middle short side spherical structure and preparation method thereof | |
| Mahmoud et al. | Facile synthesis of high yield two dimensional zinc vanadate nanoflakes | |
| CN112125326B (en) | A kind of preparation method of continuous production of nano-cerium oxide | |
| CN104909413A (en) | Preparation method of ferric oxide nano hexagonal bipyramids | |
| CN100453469C (en) | A kind of preparation method of hematite nano cube | |
| CN103101974A (en) | Bismuth oxychloride powder and preparation method thereof | |
| CN1230472C (en) | Method for preparing nano iron oxide red | |
| Tsai | Formation of nanocrystalline cerium oxide and crystal growth | |
| Khaksar et al. | Synthesis, structural characterization and reactivity of manganese tungstate nanoparticles in the oxidative degradation of methylene blue | |
| CN102616748A (en) | Method for preparing nanometer metallic oxide by bulk metallic oxide |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20131127 Termination date: 20151230 |
|
| EXPY | Termination of patent right or utility model |